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In 1822, the French Egyptologist Jean-Francois Cham-
pollion announced the deciphering of the Rosetta stone,
the key for translating Egyptian hieroglyphs, thereby
enabling an unprecedented insight into ancient Egypt
history. Life has its own Rosetta stone, the genetic code,
decoded by Marshall Nirenberg in 1960s. While the
genetic code is universal (albeit exceptions) and has not
undergone major changes since the last universal com-
mon ancestor, technological progress allows synthetic
biologists to increasingly re-write the biological Rosetta.
Researchers can set new rules at several levels of
life’s language. First, the language can be modiﬁed at its
most basic structure, the alphabet. While DNA uses only
four letters (nucleotides) to encode messages, an
extension to the alphabet can be envisioned. For
instance, a recent study reported an extended, 8-letter
(‘hachimoji’) DNA and RNA, in which the natural nucleo-
tides coexist with four synthetic building blocks (Hoshika
et al., 2019). While 4 letters can encode 64 (43) triple
codons, 8 letters can be combined to 4096 (83) codons,
thus massively increasing the information that can be
encoded. So far, the 8-letter code has only been tran-
scribed (into RNA) but not read, that is translated into a
polypeptide sequence. However, new codons generated
by a 6-letter code (63 = 216) have already been used to
incorporate non-natural amino acids (nnAAs) into pro-
teins (Zhang et al., 2017).
Researchers can also actuate on how groups of letters
(words) encode a meaning. In nature, the 64 codons
code for 20 amino acids plus the translation termination
signal. Degeneracy is a major characteristic of the
genetic code and has diverse and important roles. At the
same time, it leaves some room for recoding: the redun-
dant codon number can be reduced by obviating the use
of a given codon in favour of a synonymous one, thus
‘freeing’ the former, which can be reassigned to a nnAA.
Codon reassignment to a nnAA requires an orthogonal
translation system: the charging of the corresponding
tRNA exclusively with the reassigned amino acid by an
aminoacyl-tRNA synthetase that does not interact with
any of the other tRNAs (Chin, 2014). The most common
codon to be reassigned is the amber stop codon TAG,
which is the least abundant codon across the genome.
However, competition between the release factor 1
(RF1) and the orthogonal tRNA results in ambiguous
and inefﬁcient translation that produces variable proteins.
Moreover, uncontrolled incorporation of nnAAs into the
genome reduces cellular ﬁtness. The genome-wide re-
writing of the reassigned codon (TAG) as a synonymous
codon (e.g. TAA) and the deletion of RF1 solves this
problem. In 2011, synthetic biologists generated an
Escherichia coli strain that has all 321 TAG stop codons
replaced with TAA (Isaacs et al., 2011). This approach
has been extended to replace other synonymous codons
(Isaacs et al., 2011; Ostrov et al., 2016; Fredens et al.,
2019). To date, the largest recoded genome is that of
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E. coli Syn61 recently created by the Jason Chin labaro-
tary, in which > 18k codons were recoded to yield a 61-
codon genome (Fredens et al., 2019).
But this record will probably not last long. The collabo-
rative synthetic yeast genome project is already well
advanced in the endeavour of creating the ﬁrst synthetic
eukaryotic genome, Saccharomyces cerevisiae Sc2.0.
Among other new design features, it will have all TAG
stop codons recoded to TAA (Richardson et al., 2017).
Similarly, the synthesis of a recoded human genome is
sought by an international consortium (Boeke et al.,
2016). Inspired by the Human Genome Project (HGP-
read), which in 2004 yielded the sequence of the human
genome with the concomitant improvement of DNA
sequencing technology, cost and quality, the HGP-write
aims to engineer large genomes and thus contribute to
reduce costs of design and testing of synthetic gen-
omes.
Indeed, genome recoding is very much dependent on
the development of enabling technologies. Some gen-
ome recoding projects may require a relatively low num-
ber of changes to be made, and thus, editing the
existing genome may reveal a realistic and even a con-
venient option (Isaacs et al., 2011). However, where
large-scale modiﬁcations are desired, rebuilding the gen-
ome from chemically synthesized DNA might be more
efﬁcient. The assembly of the synthetic genome can
either be carried out sequentially, by replacing segments
in a pre-deﬁned order (Fredens et al., 2019), or simulta-
neously, by assembling the artiﬁcial genome de novo in
a single reaction from smaller constituent parts (Hutchi-
son et al., 2016). We anticipate that decreasing costs of
DNA synthesis will boost such genome-wide recoding
endeavours in the mid-term.
But, talking business, where do all these recoding
efforts lead to? Can the recoding of nature’s language
also set new rules in the life science market? Well, we
think it can. Genome recoding holds a huge potential not
only for academic research, but also for commercial
applications. First, the use of nnAAs offers great promise
for the development of new catalysts of industrial inter-
est. The 20 natural amino acids limit the number of reac-
tions that enzymes can perform. NnAAs expand the
repertoire and provide new properties that can result in
novel functions never found before in nature (Agostini
et al., 2017). As the recent Nobel Prize laureate Frances
Arnold has shown, enzyme catalysts can outperform
chemical ones, and thus, nnAAs can potentially yield
novel supercatalysts to replace conventional chemical
synthesis, which can use a lot of energy and toxic chem-
icals, with more environmentally friendly processes.
Second, therapeutic protein production can also
greatly beneﬁt from the a la carte incorporation of
nnAAs. Indeed, while currently most proteins of
therapeutic relevance are produced in eukaryotic sys-
tems, a prokaryote-based production would offer impor-
tant advantages, such as easier genetic manipulation,
faster and cheaper production, and reduced contamina-
tion rates. Yet, standard prokaryotic ‘workhorses’ like
E. coli are unable of most eukaryotic post-translational
modiﬁcations (PTMs). Codon reassignment has been
used to bypass the prokaryotic limitations and incorpo-
rate eukaryotic PTMs (Neumann et al., 2008; Nguyen
et al., 2009; Virdee et al., 2011). Similarly, nnAAs can
help improving protein functionalization, for example for
producing bispeciﬁc antibodies or antibody–drug conju-
gates, or for attaching polyethylene glycol chains (PEG)
to improve protein stability (Huang and Liu, 2018).
Third, chemical synthesis of genomes and codon reas-
signment is also a promising strategy to produce live-at-
tenuated vaccines. Viruses with genomes recoded with
synonymous mutations have been reported to trigger a
wild-type immune response since the protein sequence
is unaltered, but they have a reduced viability due to
sub-optimal replication or translation, resulting in safer
vaccines (Wang et al., 2018).
Fourth, recoded genomes can provide increased virus
resistance to their hosts, since a virus infecting a cell
with re-purposed tRNA(s) is unable to properly translate
its genes (Lajoie et al., 2013). Virus resistance is a
desirable property for (almost) any culture of (eukaryotic
or prokaryotic) cells used in industrial production of
goods such as therapeutic proteins, food or chemicals.
For example, bacteriophage contamination is a relevant
issue in industrial fermentations: in the dairy industry,
which produced 817 million tons of milk in 2016, phage
infection of the starter cultures is the main factor causing
fermentation failures (Fernandez et al., 2017).
Finally, a major advantage of recoded organisms is
their potential for biocontainment. On one hand, codon-
reassigned strains are virtually reluctant to horizontal
gene transfer (both incoming and outcoming), since
incoming DNA is unreadable in the engineered strain,
and, similarly, synthetic genes are not properly translated
in a natural host. Even more, this passive incompatibility
can be further improved via an active mechanism: a
non-recoded toxin gene in the recoded organism would
prevent the transfer of the artiﬁcial cassette to natural
strains, while selecting against reacquiring the native
tRNA machinery (Kuo et al., 2018). On the other hand,
codon reassignment also allows to make the survival of
the organism dependent on the presence of the nnAAs,
notably through the insertion of nnAAs in essential
genes (Mandell et al., 2015; Rovner et al., 2015).
As opposed to genetically modiﬁed organisms
(GMOs), improved biocontainment of genetically recoded
organisms (GROs) could have major scientiﬁc and eco-
nomic implications. From a scientiﬁc perspective, it is
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obviously desirable to keep biocontainment to a maxi-
mum, unless a strain is purposely engineered for genetic
exchange. From a socioeconomic view, a greater control
over engineered strains might have a direct impact on
public opinion and, in turn, on policy makers. Consumers
still perceive GMOs as rather negative and receive GMO
information mostly from non-scientiﬁc sources (Wunder-
lich and Gatto, 2015). Ensuring a reliable biocontainment
might serve to reassure the population and revisit restric-
tive regulations, which might have enormous economic
implications for the agricultural and biotech industries.
Ironically, while engineered organisms are still often
seen as a sort of Frankenstein, making them Franken-
steiner might actually make them safer and change the
perception of society and stakeholders.
For half a century, reading the DNA has generated
major beneﬁts to humankind, both scientiﬁcally and eco-
nomically. Now, the ability to write the DNA and to
include changes such as the here discussed genome
recoding, but also streamlining and stabilization, pro-
mises to bring a comparable revolution that will likely
imply profound changes in research, health, agriculture
and bio-based industrial production.
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